REPORT ID 489

Global Adrenoleukodystrophy Drugs Sales Market Report 2017

Publish Date
04-Dec-17
Pages
103
Format
Electronic (PDF)

In this report, the global Adrenoleukodystrophy Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Adrenoleukodystrophy Drugs for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Adrenoleukodystrophy Drugs market competition by top manufacturers/players, with Adrenoleukodystrophy Drugs sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Applied Genetic Technologies Corp
    Bluebird Bio Inc
    MedDay SA
    Minoryx Therapeutics sl
    Pfizer Inc
    ReceptoPharm Inc
    SOM Biotech SL
    Viking Therapeutics Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Biotin
    DRX-065
    DUOC-01
    Lenti-D
    MIN-102
    OP-101
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Children
    Adult

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Adrenoleukodystrophy Drugs Sales Market Report 2017
1 Adrenoleukodystrophy Drugs Market Overview
    1.1 Product Overview and Scope of Adrenoleukodystrophy Drugs
    1.2 Classification of Adrenoleukodystrophy Drugs by Product Category
        1.2.1 Global Adrenoleukodystrophy Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Adrenoleukodystrophy Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Biotin
        1.2.4 DRX-065
        1.2.5 DUOC-01
        1.2.6 Lenti-D
        1.2.7 MIN-102
        1.2.8 OP-101
        1.2.9 Others
    1.3 Global Adrenoleukodystrophy Drugs Market by Application/End Users
        1.3.1 Global Adrenoleukodystrophy Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Children
        1.3.3 Adult
    1.4 Global Adrenoleukodystrophy Drugs Market by Region
        1.4.1 Global Adrenoleukodystrophy Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Adrenoleukodystrophy Drugs Status and Prospect (2012-2022)
        1.4.3 China Adrenoleukodystrophy Drugs Status and Prospect (2012-2022)
        1.4.4 Europe Adrenoleukodystrophy Drugs Status and Prospect (2012-2022)
        1.4.5 Japan Adrenoleukodystrophy Drugs Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Adrenoleukodystrophy Drugs Status and Prospect (2012-2022)
        1.4.7 India Adrenoleukodystrophy Drugs Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Adrenoleukodystrophy Drugs (2012-2022)
        1.5.1 Global Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Global Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2022)

2 Global Adrenoleukodystrophy Drugs Competition by Players/Suppliers, Type and Application
     2.1 Global Adrenoleukodystrophy Drugs Market Competition by Players/Suppliers
        2.1.1 Global Adrenoleukodystrophy Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Adrenoleukodystrophy Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Adrenoleukodystrophy Drugs (Volume and Value) by Type
        2.2.1 Global Adrenoleukodystrophy Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Global Adrenoleukodystrophy Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Global Adrenoleukodystrophy Drugs (Volume and Value) by Region
        2.3.1 Global Adrenoleukodystrophy Drugs Sales and Market Share by Region (2012-2017)
        2.3.2 Global Adrenoleukodystrophy Drugs Revenue and Market Share by Region (2012-2017)
    2.4 Global Adrenoleukodystrophy Drugs (Volume) by Application

3 United States Adrenoleukodystrophy Drugs (Volume, Value and Sales Price)
    3.1 United States Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
        3.1.1 United States Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
        3.1.2 United States Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 United States Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
    3.2 United States Adrenoleukodystrophy Drugs Sales Volume and Market Share by Players
    3.3 United States Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
    3.4 United States Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

4 China Adrenoleukodystrophy Drugs (Volume, Value and Sales Price)
    4.1 China Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
        4.1.1 China Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
        4.1.2 China Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 China Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
    4.2 China Adrenoleukodystrophy Drugs Sales Volume and Market Share by Players
    4.3 China Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
    4.4 China Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

5 Europe Adrenoleukodystrophy Drugs (Volume, Value and Sales Price)
    5.1 Europe Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
        5.1.1 Europe Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
        5.1.2 Europe Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
    5.2 Europe Adrenoleukodystrophy Drugs Sales Volume and Market Share by Players
    5.3 Europe Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
    5.4 Europe Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

6 Japan Adrenoleukodystrophy Drugs (Volume, Value and Sales Price)
    6.1 Japan Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
        6.1.1 Japan Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
        6.1.2 Japan Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
    6.2 Japan Adrenoleukodystrophy Drugs Sales Volume and Market Share by Players
    6.3 Japan Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
    6.4 Japan Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

7 Southeast Asia Adrenoleukodystrophy Drugs (Volume, Value and Sales Price)
    7.1 Southeast Asia Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
        7.1.1 Southeast Asia Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
    7.2 Southeast Asia Adrenoleukodystrophy Drugs Sales Volume and Market Share by Players
    7.3 Southeast Asia Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
    7.4 Southeast Asia Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

8 India Adrenoleukodystrophy Drugs (Volume, Value and Sales Price)
    8.1 India Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
        8.1.1 India Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
        8.1.2 India Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 India Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
    8.2 India Adrenoleukodystrophy Drugs Sales Volume and Market Share by Players
    8.3 India Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
    8.4 India Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

9 Global Adrenoleukodystrophy Drugs Players/Suppliers Profiles and Sales Data
    9.1 Applied Genetic Technologies Corp
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Bluebird Bio Inc
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 MedDay SA
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 MedDay SA Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Minoryx Therapeutics sl
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Pfizer Inc
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Pfizer Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 ReceptoPharm Inc
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 SOM Biotech SL
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 SOM Biotech SL Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Viking Therapeutics Inc
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview

10 Adrenoleukodystrophy Drugs Maufacturing Cost Analysis
    10.1 Adrenoleukodystrophy Drugs Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Adrenoleukodystrophy Drugs
    10.3 Manufacturing Process Analysis of Adrenoleukodystrophy Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Adrenoleukodystrophy Drugs Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Adrenoleukodystrophy Drugs Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Adrenoleukodystrophy Drugs Market Forecast (2017-2022)
    14.1 Global Adrenoleukodystrophy Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Adrenoleukodystrophy Drugs Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Adrenoleukodystrophy Drugs Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Adrenoleukodystrophy Drugs Price and Trend Forecast (2017-2022)
    14.2 Global Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Adrenoleukodystrophy Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Adrenoleukodystrophy Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Adrenoleukodystrophy Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Adrenoleukodystrophy Drugs Sales Forecast by Type (2017-2022)
       14.3.2 Global Adrenoleukodystrophy Drugs Revenue Forecast by Type (2017-2022)
       14.3.3 Global Adrenoleukodystrophy Drugs Price Forecast by Type (2017-2022)
    14.4 Global Adrenoleukodystrophy Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer